中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
17期
116-117
,共2页
熄风化痰汤%缺血性中风%恢复期%风痰瘀阻型
熄風化痰湯%缺血性中風%恢複期%風痰瘀阻型
식풍화담탕%결혈성중풍%회복기%풍담어조형
Calming wind and resolving phlegm decoction%Ischemic stroke%Recovery stage%Wind-phlegm syndrome and stasis
目的探讨自拟熄风化痰汤治疗缺血性中风恢复期(风痰瘀阻型)的临床疗效。方法选取2010年1月~2013年3月在本院治疗的缺血性中风患者69例,按照随机数字表法分为实验组35例及对照组34例,实验组以自拟熄风化痰汤治疗,对照组以银杏叶胶囊治疗。比较两组患者的临床疗效和神经功能症状评分情况。结果实验组患者的总有效率为91.43%,对照组为79.41%,两组总有效率比较,差异有统计学意义(P<0.05)。两组患者神经症状评分治疗后与治疗前比较,差异有统计学意义(P<0.05);治疗后实验组与对照组比较,差异有统计学意义(P<0.05)。结论自拟熄风化痰汤治疗缺血性中风恢复期(风痰瘀阻型)疗效优于西药治疗组,值得临床推广应用。
目的探討自擬熄風化痰湯治療缺血性中風恢複期(風痰瘀阻型)的臨床療效。方法選取2010年1月~2013年3月在本院治療的缺血性中風患者69例,按照隨機數字錶法分為實驗組35例及對照組34例,實驗組以自擬熄風化痰湯治療,對照組以銀杏葉膠囊治療。比較兩組患者的臨床療效和神經功能癥狀評分情況。結果實驗組患者的總有效率為91.43%,對照組為79.41%,兩組總有效率比較,差異有統計學意義(P<0.05)。兩組患者神經癥狀評分治療後與治療前比較,差異有統計學意義(P<0.05);治療後實驗組與對照組比較,差異有統計學意義(P<0.05)。結論自擬熄風化痰湯治療缺血性中風恢複期(風痰瘀阻型)療效優于西藥治療組,值得臨床推廣應用。
목적탐토자의식풍화담탕치료결혈성중풍회복기(풍담어조형)적림상료효。방법선취2010년1월~2013년3월재본원치료적결혈성중풍환자69례,안조수궤수자표법분위실험조35례급대조조34례,실험조이자의식풍화담탕치료,대조조이은행협효낭치료。비교량조환자적림상료효화신경공능증상평분정황。결과실험조환자적총유효솔위91.43%,대조조위79.41%,량조총유효솔비교,차이유통계학의의(P<0.05)。량조환자신경증상평분치료후여치료전비교,차이유통계학의의(P<0.05);치료후실험조여대조조비교,차이유통계학의의(P<0.05)。결론자의식풍화담탕치료결혈성중풍회복기(풍담어조형)료효우우서약치료조,치득림상추엄응용。
Objective To explore the clinical efficacy of self-defined Calming wind and resolving phlegm decoction on the wind-phlegm syndrome and stasis in the recovery stage of ischemia stroke. Methods 69 cases with ischemic stroke collected in our hospital from January 2010 to March 2013 were randomly divided into experimental group (35 cases) and control group (34 cases). The experimental group was treated with self-defined calming wind and resolving phlegm decoction, while control group was treated with ginaton capsule. The clinical efficacy and neurological symptom score of the two groups were compared. Results The total effective rate in the experimental group was 91.43%, while the control group was 79.41%, the difference of the total effective rate between two groups was statistically significant (P<0.05). There was significant difference in neurological symptom score of the two groups between before and after treatment (P < 0.05). There was significant difference in neurological symptom score after treatment between two groups (P<0.05). Conclusion The clinical efficacy of self-defined calming wind and resolving phlegm decoction on the wind-phlegm syndrome and stasis in the recovery stage of ischemia stroke is better than that of western medicine treatment group, which is worthy of clinical application.